Sermorelin, a synthetic peptide composed of the first 29 amino acids of the endogenous growth-hormone–releasing hormone (GHRH), has long captured scientific curiosity for its structural precision and ...

Image and performance-enhancing drugs (IPEDs), such as steroids and human growth hormone, can harm the heart – and it isn’t ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced preliminary, unaudited fourth quarter and full ...

Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...

Explore the scientific potential of the research peptide CJC-1295 DAC. Learn about its role in studies on cellular aging, ...

This specific 1-29 sequence is often referred to as the "functional fragment" because it contains the essential binding domain required to activate GHRH receptors in the pituitary gland.

The combination of CJC-1295 and GHRP-6 is emerging as a subject of interest in experimental research on growth hormone modulation, regenerative processes, metabolic regulation, and cellular resilience ...

Orexin receptors (OXRs), including OX1R (HCRTR1) and OX2R (HCRTR2), are G protein-coupled receptors (GPCRs) that are activated by endogenous orexin peptides (OXA and OXB) and have potential ...

Growth hormone receptor (GHR) signaling in bladder cancer is associated with advanced tumor stages and poor survival outcomes. High GHR expression in tumors up-regulates genes involved in drug ...

Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It involves intricate interactions among multiple signaling ...